|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0020507,
umls-concept:C0023688,
umls-concept:C0034719,
umls-concept:C0178324,
umls-concept:C0336867,
umls-concept:C0443199,
umls-concept:C0752063,
umls-concept:C1280500,
umls-concept:C1552644,
umls-concept:C1823153,
umls-concept:C2349976
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2004-1-23
|
|
pubmed:abstractText |
Patients with type 2 diabetes mellitus have a higher rate of restenosis following angioplasty. Peroxisome proliferator activator receptor-alpha (PPAR) and gamma ligands such as fenofibrate and rosiglitazone, respectively, have been shown to have protective effects on the vessel wall. We studied the effect of fenofibrate and rosiglitazone on intimal hyperplasia in the Zucker rat, a model for insulin resistance and type 2 diabetes mellitus, following balloon catheter-induced injury.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Fenofibrate,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Hypolipidemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cytoplasmic and Nuclear,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides,
http://linkedlifedata.com/resource/pubmed/chemical/rosiglitazone
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1074-2484
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
297-305
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:14740079-Animals,
pubmed-meshheading:14740079-Balloon Dilation,
pubmed-meshheading:14740079-Biological Markers,
pubmed-meshheading:14740079-Blood Glucose,
pubmed-meshheading:14740079-Body Weight,
pubmed-meshheading:14740079-Cholesterol,
pubmed-meshheading:14740079-Diabetes Mellitus, Type 2,
pubmed-meshheading:14740079-Disease Models, Animal,
pubmed-meshheading:14740079-Female,
pubmed-meshheading:14740079-Fenofibrate,
pubmed-meshheading:14740079-Hyperplasia,
pubmed-meshheading:14740079-Hypoglycemic Agents,
pubmed-meshheading:14740079-Hypolipidemic Agents,
pubmed-meshheading:14740079-Insulin,
pubmed-meshheading:14740079-Ligands,
pubmed-meshheading:14740079-Models, Cardiovascular,
pubmed-meshheading:14740079-Rats,
pubmed-meshheading:14740079-Rats, Zucker,
pubmed-meshheading:14740079-Receptors, Cytoplasmic and Nuclear,
pubmed-meshheading:14740079-Thiazolidinediones,
pubmed-meshheading:14740079-Transcription Factors,
pubmed-meshheading:14740079-Triglycerides,
pubmed-meshheading:14740079-Tunica Intima
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Differential effects of peroxisome proliferator activator receptor-alpha and gamma ligands on intimal hyperplasia after balloon catheter-induced vascular injury in Zucker rats.
|
|
pubmed:affiliation |
Department of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
